Scientific Sessions 2025  /  TCT at AHA: Renal Denervation for Hypertension: What Comes Next?  /  Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN
Logo

American Heart Association

  38
  0

Final ID:

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

  • Mahfoud, Felix  ( University Hospital Basel , Basel , Switzerland )
    • Author Disclosures:
    Felix Mahfoud: DO have relevant financial relationships ; Consultant:Ablative Solutions, Medtronic and ReCor Medical.:Past (completed) ; Speaker:Ablative Solutions, Astra-Zeneca, Inari, Medtronic, Merck, Novartis, Philips and ReCor Medical.:Past (completed) ; Researcher:Ablative Solutions, Medtronic and ReCor Medical.:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Renal Denervation for Hypertension: What Comes Next?

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Debate Con: RDN Will Ultimately Be a Niche Therapy

Wright Jackson, Fisher Naomi

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Cohen Debbie

More abstracts from these authors:
Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Kandzari David, Kirtane Ajay, Mahfoud Felix

National Estimates of Patient Eligibility for Renal Denervation Therapy Post-FDA Approval

Watson Nathan, Earle William, Kandzari David, Kirtane Ajay, Mahfoud Felix, Cluett Jennifer, Krawisz Anna, Juraschek Stephen, Secemsky Eric

You have to be authorized to contact abstract author. Please, Login
Not Available